Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9701043 | 0.98 | LMNA (0.32) | LMNA | |
| SCHEMBL30325641 | 0.94 | LMNA (0.34) | LMNA | |
| SCHEMBL30325621 | 0.94 | LMNA (0.34) | LMNA | |
| SCHEMBL30325614 | 0.94 | LMNA (0.34) | LMNA | |
| SCHEMBL30325651 | 0.94 | LMNA (0.34) | LMNA | |
| SCHEMBL2458234 | 0.92 | CA12 (0.39) | LMNA | |
| SCHEMBL537901 | 0.91 | CYP2C19 (0.33) | — | |
| SCHEMBL19554057 | 0.91 | CA12 (0.39) | LMNA | |
| SCHEMBL15455698 | 0.89 | CA12 (0.37) | LMNA | |
| SCHEMBL1638782 | 0.89 | CYP2C19 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159709-A1 | Amine Functionalized Siloxane Resin Particles | AGFA NV (BE) | 2023-05-25 | — | — | US | disclosed |
| US-20180206342-A1 | MANUFACTURING PRINTED CIRCUIT BOARDS USING UV FREE RADICAL CURABLE INKJET INKS | AGFA-GEVAERT (BE) | 2018-07-19 | — | — | US | disclosed |
| US-8840751-B2 | Bonding compositions | Henkel IP & Holding GmbH (DE) | 2014-09-23 | — | — | US | disclosed |
| US-20120164904-A1 | BONDING COMPOSITIONS | LOCTITE (R&D) LIMITED (IE) | 2012-06-28 | — | — | US | disclosed |
| US-8153268-B1 | Polymer to metal bonding and compounds and compositions useful therefor | LOCTITE (R&D) LIMITED (IE) | 2012-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120164904-A1 | BONDING COMPOSITIONS | AOX1, NOXO1, RIOX2 | LMNA 2591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.